Cananbidiol (CBD) may be a useful tool for combatting periodontitis, according to a new placebo-controlled, double-blind, randomized clinical trial.
Published by the Journal of Periodontal Research, the study was conducted by researchers at Palacky University, the University Hospital Olomouc, Masaryk University and the Institute of Chemical Process Fundamentals of the Czech Academy of Sciences, all in the Czech Republic.
The aim of this study “was to: (1) evaluate the anti-inflammatory effects of cannabidiol (CBD) on primary cultures of human gingival fibroblasts (HGFs) and (2) to clinically monitor the effect of CBD in subjects with periodontitis.”
Continue reading